Why the study?
Does inhibition of central sympathetic outflow or transfection of Cx43 normalize neurovascular transmission and vasoconstriction in a mouse model of CKD hypertension?
Does inhibition of central sympathetic outflow or transfection of Cx43 normalize neurovascular transmission and vasoconstriction in a mouse model of CKD hypertension?
Enhanced sympathetic discharge in CKD impairs Cx43 expression at myoendothelial junctions, interrupting anticontractile responses and contributing to hypertension.
No takes yet. Share an insight, caveat, or question.
Teng et al. (1963) studied Chronic kidney disease (CKD) hypertension. 5/6-nephrectomy (5/6Nx) vs. Sham was evaluated on Mesenteric vascular resistance and mean arterial pressure with carotid artery occlusion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: